MAN1A1 and carcinoma: These N-glycans are frequently associated with breast cancer metastases, with Man9 linked to worse clinical outcomes in high-grade tumors [15,16] and Man3 showing increased levels in benign breast tumor tissues compared to para-carcinoma tissues [17].